Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

NEW
STU:4E2 (USA)  
€ 4.56 -0.020 (-0.44%) Jul 28
At Loss
P/B:
2.51
Market Cap:
€ 483.91M ($ 550.96M)
Enterprise V:
€ 278.11M ($ 316.65M)
Volume:
2.00K
Avg Vol (2M):
1.94K
Trade In:
Volume:
2.00K
At Loss

Relmada Therapeutics Inc (STU:4E2) Dividend

Relmada Therapeutics Inc (STU:4E2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -34.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:4E2 Dividend

Does Relmada Therapeutics Inc (STU:4E2) pay a dividend?

Relmada Therapeutics Inc (STU:4E2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Relmada Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Relmada Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -34.6% over the past 3 years.

What are dividend-paying alternatives to Relmada Therapeutics Inc?

For dividend-paying alternatives in Relmada Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.